Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07055386
What this trial is testing

Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Gan & Lee Pharmaceuticals. 90
Post-approval studies (Phase 4)Study completedNCT02738151
What this trial is testing

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 929
Large-scale testing (Phase 3)Looking for participantsNCT07282041
What this trial is testing

Role of GLP1 RA Dulaglutide on Severe Intracranial Atherosclerosis

Who this might be right for
Intracranial AtherosclerosisStroke, Ischemic
National University of Singapore 130
Not applicableUnknownNCT05492305
What this trial is testing

Glucagon-like Peptide 1 (GLP1) Receptor Agonists and Mental Health

Who this might be right for
Diabetes MellitusObesityMental Health Issue
King's College London 20
Not applicableNot Yet RecruitingNCT07130396
What this trial is testing

Impact of Multivitamin (PhytoMulti®) and a Probiotic (UltraFlora® Balance Probiotic) on Gut Health of People Taking GLP-1 Medication

Who this might be right for
GLP-1Adults
Metagenics, Inc. 100
Not applicableLooking for participantsNCT07229170
What this trial is testing

Changes in Taste and Eating Habits Associated With GLP-1 Agonists in Weight Loss Patients

Who this might be right for
Obesity & OverweightTaste AlterationsWeight Loss+1 more
San Raffaele Telematic University 150
Post-approval studies (Phase 4)Looking for participantsNCT07136714
What this trial is testing

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Who this might be right for
Major Depressive Disorder
Nordsjaellands Hospital 116
Large-scale testing (Phase 3)Study completedNCT00715624
What this trial is testing

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 496
Large-scale testing (Phase 3)UnknownNCT02584582
What this trial is testing

The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

Who this might be right for
Type 1 Diabetes
Hvidovre University Hospital 10
Not applicableStudy completedNCT07281196
What this trial is testing

Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea

Who this might be right for
Sleep Apnea Syndrome (OSAS)
Shanghai Fengxian District Central Hospital 15
Not applicableEnrolling By InvitationNCT07140289
What this trial is testing

Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RA) on Gastric Emptying

Who this might be right for
Gastric EmptyingGlucagon-Like Peptide-1 Receptor AgonistsIntermittent Fasting+2 more
Wael Saasouh, MD 100
Large-scale testing (Phase 3)Study completedNCT01676116
What this trial is testing

The Efficacy of Insulin Degludec/Liraglutide in Controlling Glycaemia in Adults With Type 2 Diabetes Inadequately Controlled on GLP-1 Receptor Agonist and OAD Therapy

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 438
Not applicableUnknownNCT03768518
What this trial is testing

GLP-1 Receptor Expression in CHI

Who this might be right for
Congenital Hyperinsulinism
Radboud University Medical Center 40
Not applicableNot Yet RecruitingNCT07723820
What this trial is testing

Glycemic Velocity and Early Retinal Microvascular Change With GLP-1RA Versus SGLT2i Initiation in Type 2 Diabetes (GLIDE)

Who this might be right for
Type 2 Diabetes MellitusDiabetic Retinopathy (DR)
Thammasat University Hospital 126
Not applicableActive Not RecruitingNCT07457424
What this trial is testing

Direct Measurement of Microstructure of Ingestive Behaviour After Initiation of GLP-1 Receptor Agonist Treatment at Maximum Dose (DIGRAT)

Who this might be right for
Metabolic DiseaseObesity & Overweight
University College Dublin 140
Testing effectiveness (Phase 2)Study completedNCT06851858
What this trial is testing

Efficacy, Safety and Tolerability of AZD6234 in Participants Living With Overweight or Obesity With Type 2 Diabetes Who Are on a Stable Dose of GLP-1 Receptor Agonist

Who this might be right for
EndocrinologyDiabetes, Type IIObesity
AstraZeneca 69
Testing effectiveness (Phase 2)Study completedNCT05302596
What this trial is testing

Semaglutide Use in Elderly Obese Patients

Who this might be right for
ObesityAging
State University of New York at Buffalo 16
Post-approval studies (Phase 4)Study completedNCT02276196
What this trial is testing

Effect of LIXIsenatide on the Renal System

Who this might be right for
Diabetic Kidney DiseaseDiabetic NephropathyDiabetes Mellitus+1 more
Amsterdam UMC, location VUmc 40
Post-approval studies (Phase 4)Not Yet RecruitingNCT07251556
What this trial is testing

GLP-1 Receptor Agonists in Non-diabetic Patients With Psoriatic Arthritis

Who this might be right for
Psoriasis Arthritis
Chinese University of Hong Kong 40
Post-approval studies (Phase 4)Study completedNCT03331289
What this trial is testing

Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

Who this might be right for
Diabetes Mellitus, Type 2
The University of Texas Health Science Center at San Antonio 107
Next Page